Topical Antifungal Treatment for Tinea Cruris

Phase 3CompletedNCT01342315

Medicis Global Service Corporation483 enrolled

Overview

To determine if a topical antifungal cream is safe and effective for the treatment of tinea cruris

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

483

Daily dosing

Daily dosing

Sex: ALLMin age: 12 Years

Medical Language ↔ Plain English

Inclusion Criteria: * moderate erythema, mild scaling, and moderate pruritis Exclusion Criteria: * pregnancy and allergies

Unnamed facility

Fremont, California, United States

Unnamed facility

Los Angeles, California, United States

Unnamed facility

Proportion of patients achieving complete clearance

Signs and Symptoms Severity Score and negative Potassium Hydroxide (KOH) and Culture

Time frame: 3 weeks post-treatment

Proportion of patients achieving effective treatment

Clinical Cure and Mycological Cure

Time frame: 1 week Post Treatment, 2 weeks Post Treatment, and 3 weeks Post Treatment

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.